Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy

Study summary

Our objective is to assess whether the use of high flow nasal cannula (Vapotherm, Exeter, NH) with monitored anesthesia care (MAC) during an endobronchial ultrasound (EBUS) bronchoscopy procedure will lead to less procedure interruptions, less hypoxic episodes, shorter duration of hypoxic episodes and shorter procedural durations when compared to regular MAC using a regular nasal canula.

Ask AI to explain this study

Start here

Key things to know

Main goalSupportive Care

This describes the study’s primary purpose.

What is being studiedVapotherm and Regular nasal canula

The study team can explain what participation involves.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Sep 25, 2025 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?The Cooper Health System

Study sponsor

Study overview

What this study is about

Purpose: Supportive Care
Study type: Interventional
Phase: Not applicable
Sponsor: The Cooper Health System
Interventions being studied: Device: Vapotherm; Device: Regular nasal canula

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

age\>18 years
patient undergoing EBUS bronchoscopy with moderate conscious sedation.

Reasons someone may not be able to joinExclusion criteria

subjects with previous nasal surgeries
subjects with oxygen saturation \<90% on room air prior to procedure
subjects who are pregnant
subjects with known facial fractures or recent facial trauma
subjects on any anticoagulation that cannot be discontinued prior to the procedure

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Cooper University HospitalCamden, New Jersey

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Sep 25, 2025. Always confirm current availability with the study team.

View original record ↗